Atlas Trials

A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease

Clinical trial NCT00002337 · COMPLETED

Trial details

NCT number
NCT00002337
Sponsor
Otsuka America Pharmaceutical
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infections
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.